This review summarizes important studies regarding Helicobacter pylori therapy published
from April 2019 to April 2020. The main themes that emerge involve studies assessing …

The main challenge in the field of Helicobacter pylori (H. pylori) infection is antibiotic
resistance, which influences the efficacy of eradication regimens. Bismuth-containing …

Introduction The eradication rates for Helicobacter pylori have decreased in Korea although
the prevalence of this bacterium has also decreased. Antibiotic resistance is likely to be a …

Background Treating Helicobacter pylori infection according to antibiotic resistance has
been frequently recommended. However, information on its real effectiveness is scarce. Aim …

Helicobacter pylori infects approximately 50% of the world's population and is considered
the major etiological agent of severe gastric diseases, such as peptic ulcers and gastric …

Background Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori
(H. pylori) is crucial for decision of the most appropriate eradication therapies with good …

ABSTRACT Introduction: Eradication of Helicobacter pylori (H. pylori) becomes more
challenging due to increasing antimicrobial resistance. Consequently, the performance of …

Helicobacter pylori (HP) is a major causative agent of chronic gastritis and peptic ulcer. HP
is also engaged in the development of gastric cancer and gastric mucosa-associated …

Antibiotic resistance is the major reason for Helicobacter pylori treatment failure, and the
increasing frequency of antibiotic resistance is a challenge for clinicians. Resistance to …

Abstract Background Failure of Helicobacter pylori (H. pylori) eradication is principally
caused by antimicrobial resistance. Nowadays, multidrug resistance could be a major …